Knowing the factors that may put you at an increased risk of bladder cancer enables you to take simple precautions to lower your risk and protect your health. Combined with knowledge of the common symptoms of bladder cancer, awareness of risk also helps to inform decisions regarding diagnostic testing.
In this video, we look at bladder cancer risk factors. To learn more about bladder cancer risk and what causes the disease, please visit: www.cxbladder.com/bladder-can....
If you're concerned about bladder cancer, ask your doctor about Cxbladder
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer in hematuria patients and those being monitored for bladder cancer recurrence. The test combines clinical risk factor markers with genetic information, measuring five biomarker genes to detect the presence or absence of bladder cancer.
Cxbladder gives you certainty, resolving diagnostic ambiguity and improving overall detection accuracy. Most patients experiencing hematuria or who are being monitored for bladder cancer recurrence do not have cancer. Cxbladder enables the accurate rule out of patients who do not have bladder cancer, reducing the need for further invasive tests.
With performance proven in 12 peer-reviewed studies, Cxbladder is trusted by over 1,800 US urologists in over 40,000 patients. The test is covered by Medicare and comes with the option of in-home sampling.
In New Zealand, Cxbladder is now accessible to 65% of the population via public healthcare. We offer the test to all other residents via our online shop.
Learn more bladder cancer and Cxbladder at: www.cxbladder.com